Oxford Biomedica is a global cell and gene therapy company with capabilities across key viral vector types and a focus on delivering life changing therapies to patients.
We provide innovative solutions to cell and gene therapy biotechnology and biopharma companies for their process development, analytical development and manufacturing needs.
From our unique LentiVector® lentiviral vector delivery platform to high-performing, full scope AAV manufacturing and innovation, OXB is a pioneer of cell and gene therapy. Discover more about our services below.
